Podcast

Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF

10/11/2019

 

In this podcast, Andrew Limper, MD, discusses his latest research on 2 antifibrotic drugs for the treatment of idiopathic pulmonary fibrosis, which was recently published by the American Thoracic Society.

Andrew H. Limper, MD, is the Robert D. and Patricia E. Kern Associate Dean of Practice Transformation and Walter and Leonore Annenberg Professor of Pulmonary Medicine at Mayo Clinic in Rochester, Minnesota. He is also a pulmonary and critical care physician at Mayo Clinic in Rochester, Minnesota, and a professor of Biochemistry and Molecular Biology and Medicine at the Mayo Clinic College of Medicine and Science.

Additional Reading:

  • Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH. Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(2):168-174. https://doi.org/10.1164/rccm.201902-0456OC. 

 

Published in partnership with American Thoracic Society

Related Content

Cardiovascular Diseases
Cardiovascular Diseases
Seth Baum, MD, on Heart Failure: Clinical, Payer Considerations
03/28/2018
Dr Seth Baum, president of the American Society for Preventive Cardiology, welcomes you to our new podcast series and leaves clinicians with a tip for gaining access to heart failure medication.
03/28/2018
mutations
mutations
Intracellular Monitoring of Viral Infections
07/05/2022
In this podcast, Laura Fabris, PhD, from Rutgers University, answers our questions about how her research team identified and quantified RNA mutations in the influenza A virus...
07/05/2022
Lupus Nephritis
Lupus Nephritis
Gary Gilkeson, MD, on Lupus and Lupus Nephritis Among Black Patients
05/24/2011
Dr Gilkeson, from the Medical University of South Carolina, discusses findings of research into the prevalence of systemic lupus erythematosus and lupus nephritis among the African-American population,...
05/24/2011
Cardiometabolic Risk
Cardiometabolic Risk
Michael Bloch, MD, on the New "Prehypertension"
06/27/2018
<p>Dr Michael Bloch from Blue Spruce Medical Consultants talks about the ACP's new hypertension guidance, the new "prehypertension" group of patients, and more.</p>
06/27/2018
Primary Care
Primary Care
David Cennimo, MD, on What to Tell Your Patients This Flu Season
10/21/2019
Dr Cennimo outlines lessons learned from last year's influenza season, this year's vaccination options, and important points to emphasize with patients.
10/21/2019